X‑Chem Marks the Spot for Bayer in Sweetened Drug Discovery Deal
July 13 2016 | BIOWORLD TODAY | Bayer AG and privately held X-Chem Inc. expanded their global drug discovery collaboration, initiated in 2012, to encompass the entire bandwidth of therapeutic areas and target classes from Bayer’s R&D pipeline.